ES2042437T1 - Procedimiento de preparacion de una lipoproteina modificaa por incorporacion de una substancia activa lipofila. - Google Patents

Procedimiento de preparacion de una lipoproteina modificaa por incorporacion de una substancia activa lipofila.

Info

Publication number
ES2042437T1
ES2042437T1 ES91913037T ES91913037T ES2042437T1 ES 2042437 T1 ES2042437 T1 ES 2042437T1 ES 91913037 T ES91913037 T ES 91913037T ES 91913037 T ES91913037 T ES 91913037T ES 2042437 T1 ES2042437 T1 ES 2042437T1
Authority
ES
Spain
Prior art keywords
lipoprotein
incorporation
preparation
modified
substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
ES91913037T
Other languages
English (en)
Inventor
Gilles Favre
Patrick Duriez
Francoise Monard
Samadi-Baboli Medhi
Georges Soula
Jean-Charles Fruchart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Université Lille 2 Droit et Santé
Université de Toulouse
Original Assignee
Université Lille 2 Droit et Santé
Universite Toulouse III Paul Sabatier
Université de Toulouse
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Université Lille 2 Droit et Santé, Universite Toulouse III Paul Sabatier, Université de Toulouse filed Critical Université Lille 2 Droit et Santé
Publication of ES2042437T1 publication Critical patent/ES2042437T1/es
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1275—Lipoproteins or protein-free species thereof, e.g. chylomicrons; Artificial high-density lipoproteins [HDL], low-density lipoproteins [LDL] or very-low-density lipoproteins [VLDL]; Precursors thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

METODO DE PREPARACION DE UNA LIPOPROTEINA MODIFICADA POR INCORPORACION DE AL MENOS UNA SUSTANCIA ACTIVA LIPOFILA DISTINTA DE UN TRIGLICERIDO, CARACTERIZADO EN QUE SE INCORPORA DICHA SUSTANCIA ACTIVA A UNA EMULSION DE UNA FASE LIPIDICA EN UNA FASE CONTINUA ACUOSA, EN QUE SE AÑADE A LA EMULSION, AGITANDO, UNA LIPOPROTEINA INICIAL Y AL MENOS UNA PROTEINA DE TRANSFERENCIA DE LIPIDOS, EN QUE SE AISLA SEGUN LOS METODOS CONOCIDOS LA LIPOPROTEINA EN LA QUE LA SUSTANCIA ACTIVA ESTA INCORPORADA; LIPOPROTEINA MODIFICADA ASI OBTENIDA, Y COMPOSICION FARMACEUTICA O COSMETICA QUE CONTIENE TAL LIPOPROTEINA MODIFICADA.
ES91913037T 1990-07-13 1991-07-12 Procedimiento de preparacion de una lipoproteina modificaa por incorporacion de una substancia activa lipofila. Pending ES2042437T1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9008980A FR2664500B1 (fr) 1990-07-13 1990-07-13 Procede de preparation d'une lipoproteine modifiee par incorporation d'une substance active lipophile, lipoproteine modifiee ainsi obtenue et composition pharmaceutique ou cosmetique la contenant.

Publications (1)

Publication Number Publication Date
ES2042437T1 true ES2042437T1 (es) 1993-12-16

Family

ID=9398707

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91913037T Pending ES2042437T1 (es) 1990-07-13 1991-07-12 Procedimiento de preparacion de una lipoproteina modificaa por incorporacion de una substancia activa lipofila.

Country Status (11)

Country Link
US (1) US5324821A (es)
EP (1) EP0491921B1 (es)
JP (1) JPH0786089B2 (es)
AT (1) ATE133867T1 (es)
AU (1) AU654144B2 (es)
CA (1) CA2066416A1 (es)
DE (1) DE69117029T2 (es)
ES (1) ES2042437T1 (es)
FR (1) FR2664500B1 (es)
GR (1) GR920300128T1 (es)
WO (1) WO1992000761A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869534A (en) * 1992-05-21 1999-02-09 The Picower Institute For Medical Research Glycosylation of lipids and lipid-containing particles, and diagnostic and therapeutic methods and materials derived therefrom
US5615801A (en) * 1990-06-06 1997-04-01 The Coca-Cola Company Juice concentrate package for postmix dispenser
US5842603A (en) * 1990-06-06 1998-12-01 The Coca-Cola Company Postmix juice dispenser
US5874059A (en) * 1992-04-02 1999-02-23 Fundacao E.J. Zerbini Microemulsions labelled with radioactivity used as means for targeting neoplastic cells
JP2001503735A (ja) * 1996-07-03 2001-03-21 ユニバーシティ オブ ピッツバーグ 親水性活性試薬のためのエマルジョン処方物
GB2321455A (en) * 1997-01-24 1998-07-29 Norsk Hydro As Lipophilic derivatives of biologically active compounds
US6514523B1 (en) 2000-02-14 2003-02-04 Ottawa Heart Institute Research Corporation Carrier particles for drug delivery and process for preparation
JP4995423B2 (ja) * 2002-12-03 2012-08-08 ブランシェット・ロックフェラー・ニューロサイエンスィズ・インスティテュート 物質を血液−脳関門を渡って輸送するための人工低密度リポタンパク質キャリア
US7803400B2 (en) 2002-12-03 2010-09-28 Blanchette Rockefeller Neurosciences Institute Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier
WO2004073684A2 (en) * 2003-02-14 2004-09-02 Children's Hospital & Research Center At Oakland Lipophilic drug delivery vehicle and methods of use thereof
DE10324256B4 (de) * 2003-05-28 2010-04-22 Merz Pharma Gmbh & Co. Kgaa Lipid-Tranferprotein-Systeme und deren kosmetische/dermatologische Anwendung
US20080253960A1 (en) * 2004-04-01 2008-10-16 The Trustees Of The University Of Pennsylvania Center For Technology Transfer Lipoprotein-Based Nanoplatforms
KR20110051214A (ko) * 2008-07-30 2011-05-17 닛토덴코 가부시키가이샤 약물 담체
CN107708670A (zh) 2015-06-01 2018-02-16 奥托泰利克有限责任公司 磷脂包衣的治疗剂纳米颗粒和有关的方法
PE20231958A1 (es) 2015-07-30 2023-12-06 Macrogenics Inc Moleculas de union a pd-1 y metodos de uso de las mismas
CN108367069B (zh) 2015-12-14 2022-08-23 宏观基因有限公司 对于pd-1和ctla-4具有免疫反应性的双特异性分子及其使用方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59163824A (ja) * 1983-03-08 1984-09-14 Hitachi Ltd アライメントスコ−プ
SE456136B (sv) * 1985-06-17 1988-09-12 Oncholab Ab Forfarande for framstellning av en med ett lipofilt biologiskt aktivt emne bemengd berare pa basis av rekonstituerat ldl (lagdensitetslipoprotein)
US5023271A (en) * 1985-08-13 1991-06-11 California Biotechnology Inc. Pharmaceutical microemulsions
FR2609399A1 (fr) * 1987-01-13 1988-07-15 Ire Celltarg Sa Procede d'incorporation d'un ou plusieurs principes actifs lipophiles dans des lipoproteines, lipoproteines obtenues et composition pharmaceutique les contenant
US5084441A (en) * 1987-03-04 1992-01-28 Shaw Jack M Acetylated low density lipoproteins: a delivery system to phagocytic cells for stimulating immunologic response and host resistance
DE3854940T2 (de) * 1987-05-20 1996-07-11 Rogosin Inst Rekonstituierte hdl-teilchen und ihre verwendung
DE3815473A1 (de) * 1988-05-06 1989-11-16 Karl Heinz Prof Dr Dr Schmidt Wirkstoff-system fuer den lipidaustausch mit zielstrukturen
US5169933A (en) * 1988-08-15 1992-12-08 Neorx Corporation Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
US5006343A (en) * 1988-12-29 1991-04-09 Benson Bradley J Pulmonary administration of pharmaceutically active substances

Also Published As

Publication number Publication date
FR2664500B1 (fr) 1994-10-28
AU654144B2 (en) 1994-10-27
ATE133867T1 (de) 1996-02-15
CA2066416A1 (fr) 1992-01-14
DE69117029D1 (de) 1996-03-21
DE69117029T2 (de) 1996-09-19
EP0491921A1 (fr) 1992-07-01
JPH0786089B2 (ja) 1995-09-20
US5324821A (en) 1994-06-28
AU8215791A (en) 1992-02-04
FR2664500A1 (fr) 1992-01-17
EP0491921B1 (fr) 1996-02-07
WO1992000761A1 (fr) 1992-01-23
JPH06500768A (ja) 1994-01-27
GR920300128T1 (en) 1993-03-16

Similar Documents

Publication Publication Date Title
ATE207738T1 (de) Verfahren zur baladung von lipidvesikeln
FI922151A0 (fi) Metall-peptidkompositioner och metoder foer stimulering av haortillvaext.
NO923624D0 (no) Heterovesikulaere liposomer
DE3874428D1 (de) Maulbeerbaumextrakte enthaltende liposomzusammensetzung.
IT8049654A0 (it) Procedimento per la preparazione di collageno biologicamente attivo ma cromolecolare e prodotto ottenuto
ES2144192T3 (es) Nuevos derivados de 1-fenil-2-dimetil-amino-metil-ciclohexan-1-ol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2194114T3 (es) Formulaciones liposomicas de mitoxantrona.
BR9903434A (pt) Composição cosmética e/ou dermatológica na forma de uma emulsão óleo-em-água, método de tratamento cosméticos, uso da composição e uso cosmético da composição
DK1308170T3 (da) Törret blodfaktorpræparat indeholdende trehalose
IT1133801B (it) Procedimento e composizione per la colorazione di sostanze contenenti cheratina
ES2038270T3 (es) Preparaciones topicas sebosupresoras.
TR199700711T1 (xx) Ciltten ge�erek v�cuda giren form�lasyon.
NO965244D0 (no) Farmasöytisk preparat inneholdende et hydrofobt aktivt stoff og et brusesystem, og fremgangsmåte til fremstilling derav
IT1116160B (it) Procedimento per la perimetria dinamica o statica di occhi umani
ES2161364T3 (es) Pseudoemulsiones estabilizadas y su procedimiento de preparacion.
AU8215791A (en) Method for preparing a lipoprotein modified by the incorporation of a lipophilic active substance
BR8401490A (pt) Composicao cosmetica para bronzeamento da pele
DE69132472D1 (de) Verfahren zur Herstellung von optisch aktivem 1,3-Butandiol
IT8368279A0 (it) 5 idrossinaftochinoni per la tintura delle fibre cheratiniche umane procedimento di tintura utilizzante tali composti e composizione tintoria contenente i composti stessi
DE59611383D1 (de) Darreichungsform zur applikation von pharmazeutischen wirkstoffen und hilfsstoffen und verfahren zur herstellung derselben
ES2096727T5 (es) Productos cosmeticos y farmaceuticos que contienen extensinas.
SE8302580D0 (sv) Substituerade iminoderivat av dihydrobensopyran och dihydrobensotiopyran och forfarande for deras framstellning
ES2005036A6 (es) Un procedimiento para tenir sustancias queratinosas.
DE69623428D1 (de) Verfahren zur Herstellung von optisch aktiven Benzhydrolverbindungen
ATE82112T1 (de) Kosmetische oder pharmazeutische zubereitung zur haar- und haarbodenbehandlung.